HCV protease inhibitors

Details for Australian Patent Application No. 2008356226 (hide)

Owner TaiGen Biotechnology Co., Ltd.

Inventors Liu, Chen-Fu; Chen, Chih-Ming; King, Chi-Hsin Richard; Lin, Chu-Chung; Lo, Pin; Chen, Rong-Jiunn; Liu, Yo-Chin; Lee, Kuang-Yuan

Agent Baldwins

Pub. Number AU-B-2008356226

PCT Pub. Number WO2009/139792

Priority 61/053,857 16.05.08 US

Filing date 4 November 2008

Wipo publication date 19 November 2009

Acceptance publication date 12 April 2012

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/139792 Priority application(s): WO2009/139792

12 April 2012 Application Accepted

  Published as AU-B-2008356226

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008356231-Integrated overload and low voltage interrupt module

2008356223-Method and apparatus using guard carriers for extra channels